Table 1 Correlation between the clinicopathologic features of CC patients and the expression of SNHG12 or miR-148a
Clinicopathologic features | Relative SNHG12 level | P value | Relative miR-148a level | P value | ||
|---|---|---|---|---|---|---|
High (%) | Low (%) | Low (%) | High (%) | |||
Age (years) | > 0.05 | > 0.05 | ||||
≥ 50 | 12 (57.1) | 9 (42.9) | 13 (61.9) | 8 (30.1) | ||
< 50 | 9 (50) | 9 (50) | 10 (55.6) | 8 (44.4) | ||
Tumor size (cm) | < 0.05 | < 0.05 | ||||
≥ 5 | 11 (68.8) | 5 (31.2) | 10 (62.5) | 6 (37.5) | ||
< 5 | 10 (43.5) | 13 (56.5) | 13 (56.5) | 10 (43.5) | ||
TNM stage | < 0.05 | < 0.05 | ||||
I + II | 9 (39.1) | 14 (60.9) | 6 (26.1) | 17 (73.9) | ||
III + IV | 12 (75.0) | 4 (25.0) | 17 (65.4) | 9 (34.6) | ||
Lymphatic metastasis | > 0.05 | > 0.05 | ||||
No | 15(60.0) | 10 (40.0) | 14 (60.9) | 9 (39.1) | ||
Yes | 6 (42.9) | 8 (57.1) | 9 (56.3) | 7 (43.7) | ||